Arena Pharmaceuticals Funding & Investors
San Diego, CA
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company’s most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), etrasimod (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn’s disease. In 2016 the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials.
arenapharm.comTotal Amount Raised: $1,059,760,000
Arena Pharmaceuticals Funding Rounds
Post Ipo Equity
$56,000,000
Post Ipo Equity Investors
Farallon Capital ManagementPost Ipo Equity
$316,300,000
Post Ipo Equity
$352,800,000
Post Ipo Equity
$79,400,000
Post Ipo Equity
$33,000,000
Post Ipo Equity
$35,500,000
Post Ipo Equity Investors
Deerfield Capital ManagementPost Ipo Equity
$151,760,000
Post Ipo Equity Investors
Deerfield Capital ManagementDeerfield ManagementPost Ipo Equity
$35,000,000
IPO
Unknown